EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Etiology-Dependent Microbiome Differences in Hepatocellular Carcinoma Development

Nevena Todorovic iD, Serena Martinelli iD, Giulia Nannini, Ralf Weiskirchen iD, Amedeo Amedei iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252413510 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Nevena Todorovic und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Dysbiosis, Gastrointestinal Microbiome, Liver Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the European Union-NextGenerationEU-National Recovery and Resilience Plan, Mission 4 Component 2-Investment 1.5-THE-Tuscany Health Ecosystem-ECS00000017-CUP B8…, European Union—NextGenerationEU—National Recovery and Resilience Plan, Mission 4 Component 2—Investment 1.5—THE—Tuscany Health Ecosystem, Ministry of University and Research (MUR), National Recovery and Resilience Plan (NRRP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic liver disease is characterised by persistent inflammation, tissue damage, and regeneration, which leads to steatosis, fibrosis, and, lastly, cirrhosis and hepatocellular carcinoma (HCC). HCC, the most prevalent form of primary liver cancer, is one of the leading causes of cancer-related mortality worldwide. The gut microbiota plays a fundamental role in human physiology, and disturbances in its critical balance are widely recognised as contributors to various pathological conditions, including chronic liver diseases, both infectious and non-infectious in nature. Growing interest in microbiota research has recently shifted the focus towards the study of intratumoural microbiota, referred to as the “oncobiome”, which can significantly impact the development and progression of HCC. In this review, we discuss existing research and provide an overview of the microbiota influence on viral hepatitis, particularly in shaping the progression of liver disease caused by the hepatitis B and hepatitis C viruses. We also explore microbial dysbiosis and its contribution to the silent and dangerous progression of non-alcoholic fatty liver disease. Additionally, we address the impact of alcohol on the liver and its interaction with the microbiota, tracing the pathway from inflammation to cirrhosis and cancer. The review emphasises the most common etiologies of hepatocellular carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularDysbiosisGastrointestinal MicrobiomeLiver NeoplasmsNon-alcoholic Fatty Liver DiseaseAnimalsHumans

Stichwörter der Autor:innen

cirrhosisfibrosisgut microbiotahepatocellular carcinomaoncobiomesteatosis

Autor:innen und Institutionen

  • Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.
  • Clinic for Infectious and Tropical Diseases, University Clinical Centre of Serbia, 11000 Belgrade, Serbia.
  • Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, D-52074 Aachen, Germany.
  • Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), 50139 Florence, Italy.

ORCID-Profile: Nevena Todorovic, Serena Martinelli, Ralf Weiskirchen, Amedeo Amedei

Förderung

  • the European Union-NextGenerationEU-National Recovery and Resilience Plan, Mission 4 Component 2-Investment 1.5-THE-Tuscany Health Ecosystem-ECS00000017-CUP B8…
  • European Union—NextGenerationEU—National Recovery and Resilience Plan, Mission 4 Component 2—Investment 1.5—THE—Tuscany Health Ecosystem
  • Ministry of University and Research (MUR), National Recovery and Resilience Plan (NRRP)
  • European Union—Next-Generation EU

Zitieren

APA

Todorovic, N., Martinelli, S., Nannini, G., Weiskirchen, R., & Amedei, A. (2024). Etiology-Dependent Microbiome Differences in Hepatocellular Carcinoma Development. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252413510

Vancouver

Todorovic N, Martinelli S, Nannini G, Weiskirchen R, Amedei A. Etiology-Dependent Microbiome Differences in Hepatocellular Carcinoma Development. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252413510

BibTeX
@article{Todorovic2024,
  author = {Todorovic, Nevena and Martinelli, Serena and Nannini, Giulia and Weiskirchen, Ralf and Amedei, Amedeo},
  title = {Etiology-Dependent Microbiome Differences in Hepatocellular Carcinoma Development},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252413510}
}
Kostenlos starten →